A Phase 1 randomized, open-label clinical trial to evaluate the effect of a far-infrared emitting patch on local skin perfusion, microcirculation and oxygenation.

van Kraaij, Sebastiaan J W; Hamblin, Michael R; Pickering, Gisele; Giannokopoulos, Bill; Kechemir, Hayet; Heinz, Moritz; Igracki-Turudic, Iva; Yavuz, Yalçin; Rissmann, Robert; Gal, Pim

van Kraaij, Sebastiaan J W; Hamblin, Michael R; Pickering, Gisele; Giannokopoulos, Bill; Kechemir, Hayet; Heinz, Moritz; Igracki-Turudic, Iva; Yavuz, Yalçin; Rissmann, Robert; Gal, Pim.

Affiliation

van Kraaij SJW; Centre for Human Drug Research, Leiden, the Netherlands.
Hamblin MR; Leiden University Medical Centre, Leiden, the Netherlands.
Pickering G; Laser Research Centre, Faculty of Health Science, University of Johannesburg, Johannesburg, South Africa.
Giannokopoulos B; Clinical Investigation Center CIC Inserm 1405, University Hospital Clermont-Ferrand, Clermont-Ferrand, France.
Kechemir H; CHC Science Hub, Sanofi, Athens, Greece.
Heinz M; Research & Development, Sanofi, Chilly-Mazarin, France.
Igracki-Turudic I; Research & Development, Sanofi, Chilly-Mazarin, France.
Yavuz Y; CHC Science Hub, Sanofi, Frankfurt, Germany.
Rissmann R; Centre for Human Drug Research, Leiden, the Netherlands.
Gal P; Centre for Human Drug Research, Leiden, the Netherlands.